東傑智能(300486.SZ):股東祥山投資完成減持146.17萬股 擬繼續清倉減持不超1.275%股份
格隆匯9月6日丨東傑智能(300486.SZ)公佈,公司於近日收到股東祥山投資《關於股份減持完成暨股份減持計劃的吿知函》。截止2021年9月3日,祥山投資披露的減持計劃實施完成,其在減持期間內合計減持公司股份146.17萬股。此次減持後,祥山投資持有公司股份518.1725萬股,佔公司總股本的1.275%。
同時,祥山投資擬定了新的一期減持計劃,其計劃自該減持計劃公吿之日起3個交易日之後6個月內,通過集中競價、大宗交易方式合計減持公司股份不超過518.1725萬股,即不超過公司總股本的1.275%;減持股份的原因系合夥企業的經營期限屆滿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.